Eicosanoids in non-febrile thermoregulation

Progress in Brain Research

Volumn 162, Issue , 2007, Pages 15-25

  Aronoff, David M ^a   Romanovsky, Andrej A ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

cyclooxygenase; endocannabinoids; endovanilloids; fever; prostaglandins; thermoregulation

Indexed keywords

ARACHIDONIC ACID; ENDOCANNABINOID; ICOSANOID; LEUKOTRIENE; LIPOXYGENASE; PROSTAGLANDIN; PROSTAGLANDIN E2;

FEVER; HUMAN; METABOLITE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THERMOREGULATION;

ANIMALS; BODY TEMPERATURE REGULATION; EICOSANOIDS; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 34447517346     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(06)62002-5     Document Type: Review

References (72)

1. Aronoff D.M., and Neilson E.G. Antipyretics: mechanisms of action and clinical use in fever suppression. Am. J. Med. 111 (2001) 304-315
2. Ayoub S.S., Botting R.M., Goorha S., Colville-Nash P.R., Willoughby D.A., and Ballou L.R. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 11165-11169
3. Baker F.C., Driver H.S., Paiker J., Rogers G.G., and Mitchell D. Acetaminophen does not affect 24-h body temperature or sleep in the luteal phase of the menstrual cycle. J. Appl. Physiol. 92 (2002) 1684-1691
4. Barney C.C., and Elizondo R.S. Prostaglandins and temperature regulation in the rhesus monkey. J. Appl. Physiol. 50 (1981) 1248-1254
5. Bizzi A., Garattini S., and Veneroni E. The action of salicylate in reducing plasma free fatty acids and its pharmacological consequences. Br. J. Pharmacol. 25 (1965) 187-196
6. Boulet L., Ouellet M., Bateman K.P., Ethier D., Percival M.D., Riendeau D., Mancini J.A., and Methot N. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J. Biol. Chem. 279 (2004) 23229-23237
7. Breyer R.M., Bagdassarian C.K., Myers S.A., and Breyer M.D. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 661-690
8. Cashin C.H., and Heading C.E. The assay of anti-pyretic drugs in mice, using intracerebral injection of pyretogenins. Br. J. Pharmacol. 34 (1968) 148-158
9. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
10. Clark W.G. Changes in body temperature after administration of antipyretics, LSD, delta 9-THC and related agents: II. Neurosci. Biobehav. Rev. 11 (1987) 35-96
11. Clark W.G., and Clark Y.L. Changes in body temperature after administration of antipyretics, LSD, delta 9-THC, CNS depressants and stimulants, hormones, inorganic ions, gases, 2,4-DNP and miscellaneous agents. Neurosci. Biobehav. Rev. 5 (1981) 1-136
12. Compton D.R., Aceto M.D., Lowe J., and Martin B.R. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther. 277 (1996) 586-594
13. Conn C.A., Franklin B., Freter R., and Kluger M.J. Role of gram-negative and gram-positive gastrointestinal flora in temperature regulation of mice. Am. J. Physiol. 261 (1991) R1358-R1363
14. Cranston, W.I., Hellon, R.F. and Mitchell, D. (1975) Is brain prostaglandin synthesis involved in responses to cold? J. Physiol., 249: 425-434.
15. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
16. Di Marzo V., Bisogno T., Melck D., Ross R., Brockie H., Stevenson L., Pertwee R., and De Petrocellis L. Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett. 436 (1998) 449-454
17. Dogan M.D., Patel S., Rudaya A.Y., Steiner A.A., Szekely M., and Romanovsky A.A. Lipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptor. Br. J. Pharmacol. 143 (2004) 1023-1032
18. Engblom D., Saha S., Engstrom L., Westman M., Audoly L.P., Jakobsson P.J., and Blomqvist A. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat. Neurosci. 6 (2003) 1137-1138
19. Fraifeld V., Paul L., Kaplanski J., Kozak W., and Kluger M.J. Evidence for the involvement of eicosanoids in the regulation of normal body temperature. J. Thermal Biol. 26 (2001) 295-297
20. Fride E., and Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231 (1993) 313-314
21. Fuller A., and Mitchell D. Oral antibiotics reduce body temperature of healthy rabbits in a thermoneutral environment. J. Basic Clin. Physiol. Pharmacol. 10 (1999) 1-13
22. Gordon C.J. Temperature Regulation in Laboratory Rodents (1993), Cambridge University Press, Cambridge
23. Guler A.D., Lee H., Iida T., Shimizu I., Tominaga M., and Caterina M. Heat-evoked activation of the ion channel, TRPV4. J. Neurosci. 22 (2002) 6408-6414
24. Helliwell R.J., Adams L.F., and Mitchell M.D. Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004) 101-113
25. Holtzman D., Lovell R.A., Jaffe J.H., and Freedman D.X. 1-delta9-Tetrahydrocannabinol: neurochemical and behavioral effects in the mouse. Science 163 (1969) 1464-1467
26. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker J.M., and Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8400-8405
27. Iida T., Shimizu I., Nealen M.L., Campbell A., and Caterina M. Attenuated fever response in mice lacking TRPV1. Neurosci. Lett. 378 (2005) 28-33
28. Ivanov A.I., Pero R.S., Scheck A.C., and Romanovsky A.A. Prostaglandin E(2)-synthesizing enzymes in fever: differential transcriptional regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R1104-R1117
29. Ivanov A.I., and Romanovsky A.A. Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front. Biosci. 9 (2004) 1977-1993
30. Jancso-Gabor A., Szolcsanyi J., and Jancso N. Irreversible impairment of thermoregulation induced by capsaicin and similar pungent substances in rats and guinea-pigs. J. Physiol. 206 (1970) 495-507
31. Jancso-Gabor A., Szolcsanyi J., and Jancso N. Stimulation and desensitization of the hypothalamic heat-sensitive structures by capsaicin in rats. J. Physiol. 208 (1970) 449-459
32. Lee H., Iida T., Mizuno A., Suzuki M., and Caterina M.J. Altered thermal selection behavior in mice lacking transient receptor potential vanilloid 4. J. Neurosci. 25 (2005) 1304-1310
33. Li S., Ballou L.R., Morham S.G., and Blatteis C.M. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res. 910 (2001) 163-173
34. Li S., Wang Y., Matsumura K., Ballou L.R., Morham S.G., and Blatteis C.M. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1(-/-) mice. Brain Res. 825 (1999) 86-94
35. Liedtke W., and Friedman J.M. Abnormal osmotic regulation in trpv4-/- mice. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13698-13703
36. Mackowiak P.A. Brief history of antipyretic therapy. Clin. Infect. Dis. 31 Suppl 5 (2000) S154-S156
37. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
38. Matsumura H., Honda K., Choi W.S., Inoue S., Sakai T., and Hayaishi O. Evidence that brain prostaglandin E2 is involved in physiological sleep-wake regulation in rats. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5666-5669
39. Matsumura K., and Kobayashi S. Signaling the brain in inflammation: the role of endothelial cells. Front. Biosci. 9 (2004) 2819-2826
40. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
41. Milton A.S. Prostaglandin E1 and endotoxin fever, and the effects of aspirin, indomethacin, and 4-acetamidophenol. Adv. Biosci. 9 (1973) 495-500
42. Milton A.S. Modern views on the pathogenesis of fever and the mode of action of antipyretic drugs. J. Pharm. Pharmacol. 28 (1976) 393-399
43. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
44. Murphy P.J., Myers B.L., and Badia P. Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol. Behav. 59 (1996) 133-139
45. Nava F., Carta G., and Gessa G.L. Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats. Pharmacol. Biochem. Behav. 66 (2000) 183-187
46. Oka T., Oka K., Kobayashi T., Sugimoto Y., Ichikawa A., Ushikubi F., Narumiya S., and Saper C.B. Characteristics of thermoregulatory and febrile responses in mice deficient in prostaglandin EP1 and EP3 receptors. J. Physiol. 551 (2003) 945-954
47. Oka T., Oka K., Scammell T.E., Lee C., Kelly J.F., Nantel F., Elmquist J.K., and Saper C.B. Relationship of EP(1-4) prostaglandin receptors with rat hypothalamic cell groups involved in lipopolysaccharide fever responses. J. Comp. Neurol. 428 (2000) 20-32
48. O'Neil R.G., and Brown R.C. The vanilloid receptor family of calcium-permeable channels: molecular integrators of microenvironmental stimuli. News Physiol. Sci. 18 (2003) 226-231
49. Paul L., Fraifeld V., and Kaplanski J. Evidence supporting involvement of leukotrienes in LPS-induced hypothermia in mice. Am. J. Physiol. 276 (1999) R52-R58
50. Pertwee R.G., and Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 101-121
51. Peters-Golden M., Canetti C., Mancuso P., and Coffey M.J. Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 174 (2005) 589-594
52. Rawls S.M., Cabassa J., Geller E.B., and Adler M.W. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl )-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. J. Pharmacol. Exp. Ther. 301 (2002) 963-968
53. Rodriguez de Fonseca F., Del Arco I., Bermudez-Silva F.J., Bilbao A., Cippitelli A., and Navarro M. The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 40 (2005) 2-14
54. Romanovsky A.A., Ivanov A.I., and Shimansky Y.P. Selected contribution: ambient temperature for experiments in rats - a new method for determining the zone of thermal neutrality. J. Appl. Physiol. 92 (2002) 2667-2679
55. Rosendorff C., and Cranston W.I. Effects of salicylate on human temperature regulation. Clin. Sci. 35 (1968) 81-91
56. Saha S., Engstrom L., Mackerlova L., Jakobsson P.J., and Blomqvist A. Impaired febrile responses to immune challenge in mice deficient in microsomal prostaglandin E synthase-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 5 (2005) R1100-R1107
57. Satinoff E. Salicylate: action on normal body temperature in rats. Science 176 (1972) 532-533
58. Scales W.E., and Kluger M.J. Effect of antipyretic drugs on circadian rhythm in body temperature of rats. Am. J. Physiol. 253 (1987) R306-R313
59. Scales W.E., Vander A.J., Brown M.B., and Kluger M.J. Human circadian rhythms in temperature, trace metals, and blood variables. J. Appl. Physiol. 65 (1988) 1840-1846
60. Schiltz J.C., and Sawchenko P.E. Signaling the brain in systemic inflammation: the role of perivascular cells. Front. Biosci. 8 (2003) s1321-s1329
61. Sée G. Etudes sur l'acide salicylique et les salicylates; traitement du rhumatisme aigu et chronique, de la goutte, et de diverse affections du systeme nerveux sensitif par les slicylates. Bull. Acad. Med. (Paris) 26 (1877) 689-706
62. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
63. Solomonovich A., and Kaplanski J. Effects of salicylate and indomethacin in nonfebrile rats at different ambient temperatures. Prostaglandins Leukot. Med. 19 (1985) 161-165
64. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215 (1995) 89-97
65. Szelenyi Z., Hummel Z., Szolcsanyi J., and Davis J.B. Daily body temperature rhythm and heat tolerance in TRPV1 knockout and capsaicin pretreated mice. Eur. J. Neurosci. 19 (2004) 1421-1424
66. Tegeder I., Pfeilschifter J., and Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15 (2001) 2057-2072
67. Ushikubi F., Segi E., Sugimoto Y., Murata T., Matsuoka T., Kobayashi T., Hizaki H., Tuboi K., Katsuyama M., Ichikawa A., Tanaka T., Yoshida N., and Narumiya S. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395 (1998) 281-284
68. Valenti M., Vigano D., Casico M.G., Rubino T., Steardo L., Parolaro D., and Di Marzo V. Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell. Mol. Life Sci. 61 (2004) 945-950
69. Van Der Stelt M., and Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur. J. Biochem. 271 (2004) 1827-1834
70. Watanabe H., Vriens J., Prenen J., Droogmans G., Voets T., and Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424 (2003) 434-438
71. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5780-5785
72. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., and Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 (1999) 452-457